Novanta (NASDAQ:NOVT) Releases FY 2026 Earnings Guidance

Novanta (NASDAQ:NOVT) issued an update on its FY 2026 earnings guidance on Tuesday. The company provided earnings per share guidance of 3.660-3.710 for the period, compared to the consensus earnings per share estimate of 3.690. The company issued revenue guidance of $1.1 billion, compared to the consensus revenue estimate of $1.1 billion. Novanta also updated its Q4 2026 guidance to 0.910-0.960 EPS.

Analyst Upgrades and Downgrades

NOVT has been the subject of several analyst reports. Wall Street Zen raised shares of Novanta from a “hold” rating to a “buy” rating in a research note on Saturday. Zacks Research downgraded shares of Novanta from a “strong-buy” rating to a “hold” rating in a research report on Tuesday, October 6th. Robert W. Baird set a $194.00 target price on shares of Novanta in a research report on Friday, August 7th. Finally, Weiss Ratings restated a “hold (c-)” rating on shares of Novanta in a report on Tuesday, October 13th. One equities research analyst has rated the stock with a Buy rating and two have issued a Hold rating to the company’s stock. According to data from MarketBeat.com, Novanta has a consensus rating of “Hold” and a consensus price target of $194.00.

Novanta Stock Performance

NASDAQ:NOVT opened at $145.98 on Tuesday. The firm has a market capitalization of $5.52 billion, a PE ratio of 41.73 and a beta of 1.71. Novanta has a 1 year low of $98.27 and a 1 year high of $176.38. The company has a current ratio of 4.57, a quick ratio of 3.79 and a debt-to-equity ratio of 0.12. The firm’s fifty day simple moving average is $142.25 and its 200 day simple moving average is $142.59.

Novanta (NASDAQ:NOVT) last released its earnings results on Monday, November 9th. The technology company reported $1.05 earnings per share for the quarter, topping analysts’ consensus estimates of $0.97 by $0.08. The firm had revenue of $305.01 million during the quarter, compared to analyst estimates of $301.02 million. Novanta had a net margin of 6.00% and a return on equity of 10.83%. The business’s revenue was up 23.1% on a year-over-year basis. During the same quarter in the previous year, the business earned $0.87 EPS. On average, sell-side analysts anticipate that Novanta will post 3.70 EPS for the current year.

About Novanta

Novanta develops and manufactures precision technologies used in medical and advanced industrial applications. Its products include photonics and laser components, precision motion-control systems, machine-vision technologies, and related equipment and software.

The company’s technologies are used in areas such as medical and surgical systems, life sciences, robotics, and industrial automation. Novanta serves customers internationally, with operations and customers across North America, Europe, and Asia.

Novanta was formerly known as GSI Group and adopted the Novanta name in 2016.